Aspen Pharma Schweiz GmbH
Aspen Pharma Schweiz GmbH is a Generics company based in Baar (Zug) recorded by Swissmedic as the authorisation holder for 33 human medicines. That places it 49 of 334 authorisation holders in Switzerland. Its portfolio is concentrated in Synthetika.
Key facts
| Sector | Generics |
|---|---|
| City | Baar |
| Canton | Zug |
| Authorisation holder | Yes |
| Medicines | 33 |
| Founded | Not available |
| Employees | 1-10 |
| Parent group | Aspen Pharmacare Holdings |
| Activity | Not available |
| Website | Not available |
Medicines authorised in Switzerland
Aspen Pharma Schweiz GmbH is recorded by Swissmedic as the authorisation holder for 33 human medicines. The table shows 33 of them with product code and dispensing category.
Portfolio by product code
Portfolio by dispensing category
33 of 33 authorisations
| Name | Authorisation number | Dispensing category | ATC | First authorised |
|---|---|---|---|---|
| Alkeran | 52193 | A | L01AA03 | 1993-06-18 |
| Alkeran 2 mg | 30897 | A | L01AA03 | 1964-09-17 |
| Atorvastatin Aspen 10 mg | 70304 | B | C10AA05 | 2025-06-10 |
| Bisoprolol Aspen 5 mg | 70308 | B | C07AB07 | 2025-06-20 |
| Carbostesin 2 | 36988 | B | N01BB01 | 1972-11-16 |
| Carbostesin 5 mg/ml hyperbar | 45590 | B | N01BB01 | 1986-08-26 |
| Carbostesin-Adrenalin 2 | 33998 | B | N01BB51 | 1968-06-04 |
| Deca-Durabolin 50 mg | 26660 | B | A14AB01 | 1960-10-05 |
| Disoprivan 10 mg/ml | 47162 | B | N01AX10 | 1986-09-08 |
| Disoprivan PFS 10 mg/ml | 53943 | B | N01AX10 | 1997-03-06 |
| Emla | 46850 | B | N01BB20 | 1985-06-24 |
| Emla | 52980 | B | N01BB20 | 1995-11-14 |
| Gracial | 51193 | B | G03AB05 | 1994-07-28 |
| Imurek 50 mg | 31887 | B | L04AX01 | 1965-11-15 |
| Kemadrin | 22562 | B | N04AA04 | 1956-07-13 |
| Lanvis | 37890 | A | L01BB03 | 1973-06-01 |
| Leukeran | 23426 | A | L01AA02 | 1957-06-01 |
| Mivacron | 52290 | A | M03AC10 | 1994-11-28 |
| Nimbex 5mg/2.5ml | 53677 | B | M03AC11 | 1997-01-15 |
| Ovestin | 24122 | B | G03CA04 | 1958-05-17 |
| Ovestin Crème | 50844 | B | G03CA04 | 1991-02-06 |
| Ovestin Ovula | 47183 | B | G03CA04 | 1987-08-31 |
| Puri-Nethol | 21713 | A | L01BB02 | 1955-06-24 |
| Tracrium 10mg/ml | 45342 | B | M03AC04 | 1983-06-20 |
| Trandate | 41529 | B | C07AG01 | 1979-10-23 |
| Trandate 100 mg | 41530 | B | C07AG01 | 1978-12-05 |
| Ultiva 1 mg | 53747 | A+ | N01AH06 | 1996-11-20 |
| Voriconazol Aspen 200 mg | 70391 | A | J02AC03 | 2025-08-07 |
| Voriconazol Aspen 50 mg | 70390 | A | J02AC03 | 2025-08-07 |
| Xylocain | 52097 | B | N01BB02 | 1994-02-17 |
| Xylocain 20 mg/g | 52094 | B | N01BB02 | 1994-02-21 |
| Zoledronat osteo Aspen 5 mg/100 ml | 70611 | B | M05BA08 | 2025-12-12 |
| Zyloric 100 | 32917 | B | M04AA01 | 1966-10-07 |
Frequently asked questions
How many medicines does Aspen Pharma Schweiz GmbH have authorised in Switzerland?
Aspen Pharma Schweiz GmbH is recorded by Swissmedic as the authorisation holder for 33 human medicines (as of 1 September 2026). Different strengths under one authorisation number are not counted separately.
Where is Aspen Pharma Schweiz GmbH based?
The Swiss location recorded for Aspen Pharma Schweiz GmbH is Baar, Zug.
Is Aspen Pharma Schweiz GmbH a Swissmedic authorisation holder?
Yes. Aspen Pharma Schweiz GmbH appears in the official Swissmedic list of authorised medicinal products as an authorisation holder. Under the Therapeutic Products Act (TPA) the holder is responsible for the quality, safety and product information of its medicines in Switzerland.